Compass Therapeutics, Inc.CMPXNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, modest growth trend.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-54.87M
↓ 21% below average
Average (6y)
$-45.19M
Historical baseline
Range
High:$-25.41M
Low:$-80.19M
CAGR
+7.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-54.87M | -13.2% |
| 2023 | $-48.47M | -21.9% |
| 2022 | $-39.75M | +50.4% |
| 2021 | $-80.19M | -215.6% |
| 2020 | $-25.41M | +20.4% |
| 2019 | $-31.93M | +10.6% |
| 2018 | $-35.73M | - |